Effect of Fetal Nicotine Exposure on Primate Lung

    Project: Research project

    Description

    DESCRIPTION (provided by applicant): Despite strong anti-smoking campaigns, in 2003, 11 % of American women smoked during pregnancy corresponding to over 400,000 smoke-exposed infants. Smoking during pregnancy leads to intrauterine growth retardation, premature delivery and has been estimated to cause 10% of infant and fetal mortality. Developing lung is particularly sensitive to maternal smoking and effects include decreased lung function, increased respiratory diseases and increased incidence of sudden infant death syndrome (SIDS). Given the unfortunate prevalence of smoking during pregnancy and the resulting serious consequences, it is of major importance to understand the mechanisms underlying smoking-induced changes in the newborn and to use this knowledge to prevent those changes. In our previous grant period we demonstrated that many of the effects of smoking during pregnancy on lung development are caused by nicotine crossing the placenta to interact with nicotinic receptors in the developing lung. We further demonstrated that prenatal nicotine exposure decreased pulmonary function of newborn monkeys and produced changes in connective tissue in their lungs. In exciting preliminary data we have found that maternal vitamin C supplementation can prevent some of the detrimental effects of prenatal nicotine exposure on lung function. In this application we will characterize how vitamin C supplementation prevents the effects of nicotine on lung function and further characterize the molecular mechanisms underlying the effects of prenatal nicotine exposure on lung function and development. Specifically we propose to: 1. Determine if vitamin C supplementation can prevent the effects of nicotine on lung function and development; 2. Identify critical periods for the effects of nicotine and vitamin C on lung development; 3. Characterize the mechanisms by which nicotine affects lung function and development; and 4. Use the newly developed Affymetrix rhesus monkey microarray chips to determine which effects of maternal smoking on gene expression in newborn lung are due to nicotine and which are due to other components of cigarette smoke. These studies will be approached using a non-human primate model in which timed pregnant rhesus monkeys are exposed to nicotine, and then pulmonary function of offspring studied at birth and correlated with changes in lung morphology and gene expression. Because of the close relationship between monkey lung and human lung these results will provide a clear path for clinical studies on the utility of vitamin C supplementation to prevent some of the effects of maternal smoking during pregnancy on offspring's lung function.
    StatusFinished
    Effective start/end date2/1/991/31/13

    Funding

    • National Institutes of Health: $649,622.00
    • National Institutes of Health: $683,763.00
    • National Institutes of Health: $760,521.00
    • National Institutes of Health: $736,019.00
    • National Institutes of Health: $765,738.00

    Fingerprint

    Nicotine
    Primates
    Lung
    Smoking
    Ascorbic Acid
    Pregnancy
    Mothers
    Macaca mulatta
    Smoke
    Haplorhini
    Fetal Mortality
    Gene Expression
    Sudden Infant Death
    Fetal Growth Retardation
    Organized Financing
    Nicotinic Receptors
    Infant Mortality
    Tobacco Products
    Connective Tissue
    Placenta

    ASJC

    • Medicine(all)